An observational study in Lung Carcinoma, sponsored by Guangdong Provincial People's Hospital. Not yet recruiting. Open to participants aged 15 Years to 100 Years. Per ClinicalTrials.gov, last updated 2025-09-12.
Sponsored by Guangdong Provincial People's Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Lung Neoplasms by Guangdong Provincial People's Hospital — 7 open to participants now, 7 under way, none of them phase 3. Lung Neoplasms · Guangdong Provincial People's Hospital.
Among the 12 studies in Lung Neoplasms by Guangdong Provincial People's Hospital, this one is one of 3 that started in 2025, is one of 9 observational ones, and was the 11th registered.
5,434 studies on the registry are indexed under Lung Neoplasms; 1,350 are open to participants now.
Browse Lung Neoplasms studies →7 of the 12 studies in Lung Neoplasms by Guangdong Provincial People's Hospital are open now, in 1 country. Recruiting first, the newest first:
Guangdong Provincial People's Hospital · Sites in China
Ages 18–80
Guangdong Provincial People's Hospital · Sites in China
Ages 18–80
Guangdong Provincial People's Hospital · Sites in China
Ages 18–75
Guangdong Provincial People's Hospital · Sites in China
Ages 18+
Guangdong Provincial People's Hospital · Sites in China
Ages 18+
By country, each count listing its studies:
Of the 997 Lung Neoplasms studies recruiting now, 686 (69%) set no upper age limit and 143 (14%) stop at 75 or younger; 45 take children under 18; 143 take healthy volunteers.
This study: 15 Years to 100 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is below the median of 200 across 1,436 observational studies indexed under Lung Neoplasms.
Median enrollment 100 across the 3 interventional studies, 300 across the 9 observational. Of the 1 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Guangdong Provincial People's Hospital is the lead sponsor of 237 studies on the registry; 102 are open to participants now.
2 of the studies in Lung Neoplasms by Guangdong Provincial People's Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06215326Guangdong Provincial People's HospitalShort-term Effects of Preoperative Exercise in Moderate-to-high Perioperative Risk Lung Cancer Patients | 2026-12-31 |
| NCT07170046Guangdong Provincial People's HospitalPredictive Value of CEA and ctDNA in Lung Cancer Recurrence | 2027-08-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 12 studies in Lung Neoplasms by Guangdong Provincial People's Hospital, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The study aims to investigate the predictive value of CEA levels for postoperative recurrence in the highly sensitive CEA lung cancer patients and to explore whether the dynamic changes of postoperative CEA and MRD in this population are related.This study was carried out to accurately predict the recurrence time, save the time and cost of changing the intervention strategy, and provide more personalized treatment for patients.
This study will collect two groups of cohorts: prospective and retrospective.
Patients from Guangdong Provincial People's Hospital
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The clinical information of the population in this cohort was retrospectively collected.
The clinical information of the population in this cohort was prospectively collected.
Postoperative tumor recurrence or progression
If the tumor recurs or progresses within 2 years, it will be marked as 1. If not, it will be marked as 0.
Time frame: 2 years
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Sep 2025; primary completion for Aug 2027, 22 months later.
Of 592 non-industry observational studies under Lung Neoplasms, half reached primary completion within 65 months of starting (the median), counting those still running; a quarter within 25 and three quarters within 162. This study's planned 22 months is below that.
Counting every sponsor, half of 682 studies reached it within 57 months; a quarter within 25 and three quarters within 135.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Guangdong Provincial People's Hospital →